about
Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosisPrimary cultures of glomerular parietal epithelial cells or podocytes with proven originQuantitative Micro-Computed Tomography Imaging of Vascular Dysfunction in Progressive Kidney DiseasesRenal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust fibre amositeEpiplakin deficiency aggravates murine caerulein-induced acute pancreatitis and favors the formation of acinar keratin granulesEpiplakin attenuates experimental mouse liver injury by chaperoning keratin reorganizationInduction of progressive glomerulonephritis by podocyte-specific overexpression of platelet-derived growth factor-DBiological responses to PDGF-AA versus PDGF-CC in renal fibroblasts.EP4: a new piece in the fibrotic puzzle.Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption.In vivo phage display--a discovery tool in molecular biomedicine.Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potentialCommon histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis.IL-6 Trans-Signaling Drives Murine Crescentic GNMacrophage Migration Inhibitory Factor Mediates Proliferative GN via CD74Role of T cells and dendritic cells in glomerular immunopathology.Oxidative DNA damage and its repair in rat spleen following subchronic exposure to anilineProximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration.The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?Renal fibrosis: novel insights into mechanisms and therapeutic targets.Chronic kidney disease growth factors in renal fibrosis.PDGF and the progression of renal disease.Keratins in health and disease.Renal allograft fibrosis: biology and therapeutic targets.The regenerative potential of parietal epithelial cells in adult mice.Genetic regulatory effects modified by immune activation contribute to autoimmune disease associations.PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis.Macrophage Migration Inhibitory Factor Limits Renal Inflammation and Fibrosis by Counteracting Tubular Cell Cycle Arrest.Salivary markers of kidney function - Potentials and limitations.Renal function following xenon anesthesia for partial nephrectomy-An explorative analysis of a randomized controlled study.YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation.Treatment of Renal Fibrosis-Turning Challenges into Opportunities.Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies.Late angiotensin II receptor blockade in progressive rat mesangioproliferative glomerulonephritis: new insights into mechanisms.Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury.Y-box binding protein-1 mediates profibrotic effects of calcineurin inhibitors in the kidney.Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis.Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis.An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice.Diffusion-weighted MRI does not reflect kidney fibrosis in a rat model of fibrosis.
P50
Q26796629-B0B00634-34B9-411F-90AB-C8D2969DD819Q27304859-9BDBDFEF-52D8-4F14-92A1-C8C2BA164E23Q27342525-FE2BA058-63F8-4A9E-A95C-FB3DF07DDC5BQ28384379-9D53932A-0B34-44BD-8644-96B7B3AA45EAQ28510875-6BAFD79A-5A89-4A56-B22B-9845C1D38D78Q28512838-A501A033-599D-4EFA-8F08-27D1AB70EBD7Q28565842-FC61C669-7E22-45ED-9250-C46506D09FD9Q31108584-58887933-B0CB-4C42-A4C0-79A01A0E00A5Q33353833-7FD812A2-1E17-4EC7-AB93-EA87C1B4C696Q34542291-122ACC4F-875D-4D67-B3EE-2DEAB68626CDQ34691538-56F652E8-B67E-4C6C-904D-354F2DD23401Q35130910-4CA82D1F-CF82-4EFD-9CE0-7FF7A4745D9AQ35597308-89B6A8D7-300C-4A4D-B9F8-66B0FFFA5211Q36417912-3FD4D3A3-641D-4441-A4F2-E9BFB04424BDQ36944652-0AC5D5DC-DBF7-48C8-A722-057A6A999538Q36978927-FAC9AB88-5BAB-4525-82CB-D87276727103Q37037621-EB50DE33-973C-42F3-AE0B-BC4A2A521987Q37632721-D1D8067A-5498-48E5-8872-502F5683E8F7Q37702664-875F5A18-5C4F-48B4-AC1C-094015DE6AAAQ37788542-DCDC220F-1F34-4416-9A8C-F04DDC05B2A7Q37833133-133FCA4B-0C9D-44C8-8164-2F897BDC813EQ38185014-0B89E2EB-3C27-4D2D-8475-21B7FB188FCBQ38323285-5544BF54-4C25-45B8-A304-F66A3FD9EA98Q38359455-1EE9687D-4CF9-432A-9E1E-043D759985C8Q38545021-5A9F679D-EBB5-4A1E-AB58-BB8354E46BFEQ38621387-270612E7-E911-4CEC-AC38-A5FDA19E92EBQ38624771-5164405F-9B33-4810-80B9-05CA2B9A9B19Q38628328-AD06C098-CBB5-47BF-B7F8-F8D457012755Q38658218-3070702B-4C49-48E5-9A05-4766F1638474Q38673772-76E0C5DF-E7A0-49D3-B2DC-905AE67BAB8BQ38700854-822A07E4-7DB4-4871-8493-B2F60EEDCB08Q38747293-80B2F667-470C-4296-9921-F7F6F1D6C423Q38815983-48C00ACF-4F8F-498F-8261-316607613D9DQ39236313-E8C25493-A17A-418B-A656-E015E6419C8FQ39313049-E793B1B3-5CE9-486C-BD08-AF97F2AB0893Q39537680-8DCB304A-CB76-462C-95FE-9FB3CC6C895CQ39770825-352370FE-3807-42A4-B913-340C3B36DD03Q40393715-05FA588E-5016-4DFD-BBD5-F29C1D846229Q40645585-E1B279AF-2F81-45EA-BDAC-88A37B0CBC2BQ41512822-541D0E14-D6A8-4174-B663-BA1028B0B786
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Peter Boor
@ast
Peter Boor
@en
Peter Boor
@es
Peter Boor
@nl
Peter Boor
@sl
type
label
Peter Boor
@ast
Peter Boor
@en
Peter Boor
@es
Peter Boor
@nl
Peter Boor
@sl
prefLabel
Peter Boor
@ast
Peter Boor
@en
Peter Boor
@es
Peter Boor
@nl
Peter Boor
@sl
P214
P1053
C-7707-2011
P106
P21
P214
P2798
P31
P496
0000-0001-9921-4284
P735
P7859
viaf-103803517